Plants key for Canada’s COVID-19 vaccine contender

The leading Canadian contender in the race to produce a COVID-19 vaccine is using a breakthrough approach: plants. Quebec-based Medicago will be starting phase three of its trials later this month – but as Emanuela Campanella reports – if it’s approved, the bulk of its doses won’t initially come from Canada.

• Canada’s Medicago begins late-stage study of COVID-19 vaccine with GlaxoSmithKline
• Nova Scotia reporting 5 new cases of COVID-19, including 2 university students